Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Cancer. 2021 May 11;127(17):3145–3155. doi: 10.1002/cncr.33623

Table 2.

Characteristics of PLCO Trial Participants in the Incident and Recurrent Adenoma Analyses by Case and Control Status

Characteristic Incident adenoma
Recurrent adenoma
Cases
(n= 1221)
Controls
(n= 19,626)
Cases
(n= 862)
Controls
(n= 877)
Age in years, mean (IQR) 62.4 (8.6) 62.7 (8.3) 63.3 (7.7) 63.1 (8.4)
Male, n (%) 806 (66.0) 10,699 (54.5) 614 (71.2) 499 (56.9)
White, n (%) 1,095 (89.7) 17,187 (87.6) 786 (91.2) 836 (95.3)
Family history of colorectal cancer, n (%) 125 (10.2) 1,691 (8.6) 106 (12.3) 105 (12.0)
Body mass index in kg/m2, mean (IQR) 27.6 (5.7) 27.1 (5.4) 27.9 (5.6) 27.4 (5.6)
Physical activity >3 hours/week, n (%) 261 (21.4) 4,587 (23.4) 192 (22.3) 192 (21.9)
Cigarette smoking, n (%)
 Current 136 (11.1) 1,053 (5.4) 129 (15.0) 125 (14.3)
 Former 566 (46.4) 8,076 (41.1) 437 (50.7) 415 (47.3)
History of, n (%)
 Cardiovascular diseases1 440 (36.0) 6,859 (34.9) 314 (36.4) 310 (35.3)
 Arthritis 363 (29.7) 6,630 (33.8) 265 (30.7) 298 (34.0)
 Osteoporosis 30 (2.5) 742 (3.8) 20 (2.3) 22 (2.5)
 Diabetes mellitus 88 (7.2) 1,204 (6.1) 59 (6.8) 68 (7.8)
1

Coronary artery disease, heart attack, hypertension, stroke